Clinical hepatocyte transplantation: practical limits and possible solutions

Area of Science:

• Hepatology
• Transplantation Biology
• Regenerative Medicine

Background:

• Human hepatocyte transplantation (HTx) has demonstrated proof of principle for treating acquired and inherited liver diseases since 1992.
• Despite significant progress, clinical application of HTx is limited by several key obstacles.

Purpose of the Study:

• To identify and review the most significant obstacles hindering the clinical implementation of hepatocyte transplantation.
• To discuss proposed solutions for overcoming these limitations and enhancing therapeutic efficacy.

Main Methods:

• Review of existing clinical studies and scientific literature on hepatocyte transplantation.
• Identification and categorization of major challenges in HTx.
• Discussion of potential strategies and ongoing research for addressing these challenges.

Main Results:

• Key obstacles include limited donor cell quantity and quality, lack of clinical-grade reagents, and inadequate pre-transplant quality control.
• Challenges also encompass cell storage, methods to enhance engraftment and proliferation, post-transplant cell tracking, and optimal immunosuppression.

Conclusions:

• Addressing the identified obstacles is crucial for advancing hepatocyte transplantation as a viable clinical therapy.
• Future research should focus on improving cell sources, standardization of reagents and quality control, and refining engraftment and immunosuppression protocols.